查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1349401

鼻咽拭子市場（應用：流感、COVID-19、呼吸道合胞病毒、百日咳博德氏菌感染、MRSA 等）- 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Nasopharyngeal Swabs Market (Application: Influenza, COVID-19, Respiratory Syncytial Virus, Bordetella Pertussis Infection, MRSA, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 145 Pages | 商品交期: 2-10個工作天內

價格

鼻咽拭子市場 - 報告範圍

TMR 關於全球鼻咽拭子市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球鼻咽拭子市場的收入2017 -2031年期間，考慮2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球鼻咽拭子市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解鼻咽拭子市場。

市場概況
2023年市場價值 2.673 億美元
2031 年市場價值 3.286 億美元
年複合成長率 0.024%

該報告深入研究了全球鼻咽拭子市場的競爭格局。全球鼻咽拭子市場的主要參與者已經確定，並對每個參與者的各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球鼻咽拭子市場參與者的屬性。

目錄

第一章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 重要行業活動
  • 技術進步
  • 傳染病流行病學：依國家分類
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：按類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按類型，2017-2031
    • 泡棉棉籤
    • 非織物拭子
    • 其他
  • 市場吸引力分析：按類型

第 7 章：全球市場分析與預測：按應用分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依應用分類，2017-2031
    • 流感
    • 新冠肺炎
    • 呼吸道融合病毒
    • 百日咳博德氏菌感染
    • MRSA（抗甲氧西林金黃色葡萄球菌）
    • 其他
  • 市場吸引力分析：按應用

第 8 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 醫院
    • 診所
    • 學術界及研究機構
    • 其他
  • 市場吸引力分析：按最終用戶

第 9 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 10 章：北美市場分析與預測

第 11 章：歐洲市場分析與預測

第 12 章：亞太市場分析與預測

第 13 章：拉丁美洲市場分析與預測

第 14 章：中東和非洲市場分析與預測

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類，2022 年
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
    • CR Bard, Inc. (Becton, Dickinson and Company)
    • Medical Wire & Equipment (MWE)
    • Titan Biotech Ltd.
    • COPAN Diagnostics, Inc.
    • Miraclean Technology Co., Ltd.
    • YOCON Biology
    • Trinity Biotech
    • VIRCELL SL
    • Quidel Corporation
Product Code: TMRGL79856

Nasopharyngeal Swabs Market - Scope of Report

TMR's report on the global nasopharyngeal swabs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global nasopharyngeal swabs market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nasopharyngeal swabs market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the nasopharyngeal swabs market.

Market Snapshot
Market Value in 2023US$ 267.3 Mn
Market Value in 2031US$ 328.6 Mn
CAGR2.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nasopharyngeal swabs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nasopharyngeal swabs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nasopharyngeal swabs market.

The report delves into the competitive landscape of the global nasopharyngeal swabs market. Key players operating in the global nasopharyngeal swabs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nasopharyngeal swabs market profiled in this report.

Key Questions Answered in Global Nasopharyngeal Swabs Market Report:

  • What is the sales/revenue generated by nasopharyngeal swabs across all regions during the forecast period?
  • What are the opportunities in the global nasopharyngeal swabs market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Nasopharyngeal Swabs Market - Research Objectives and Research Approach

The comprehensive report on the global nasopharyngeal swabs market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nasopharyngeal swabs market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nasopharyngeal swabs market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nasopharyngeal Swabs Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Nasopharyngeal Swabs Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. Technological Advancements
  • 5.3. Epidemiology of Infectious Diseases, by Country/Region
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. Foam Tipped Swabs
    • 6.3.2. Non-woven Swabs
    • 6.3.3. Others
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Influenza
    • 7.3.2. COVID-19
    • 7.3.3. Respiratory Syncytial Virus
    • 7.3.4. Bordetella Pertussis Infection
    • 7.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
    • 7.3.6. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Nasopharyngeal Swabs Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Clinics
    • 8.3.3. Academia & Research Institutes
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Nasopharyngeal Swabs Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type, 2017-2031
    • 10.2.1. Foam Tipped Swabs
    • 10.2.2. Non-woven Swabs
    • 10.2.3. Others
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Influenza
    • 10.3.2. COVID-19
    • 10.3.3. Respiratory Syncytial Virus
    • 10.3.4. Bordetella Pertussis Infection
    • 10.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
    • 10.3.6. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Clinics
    • 10.4.3. Academia & Research Institutes
    • 10.4.4. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Nasopharyngeal Swabs Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2017-2031
    • 11.2.1. Foam Tipped Swabs
    • 11.2.2. Non-woven Swabs
    • 11.2.3. Others
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Influenza
    • 11.3.2. COVID-19
    • 11.3.3. Respiratory Syncytial Virus
    • 11.3.4. Bordetella Pertussis Infection
    • 11.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
    • 11.3.6. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Clinics
    • 11.4.3. Academia & Research Institutes
    • 11.4.4. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Nasopharyngeal Swabs Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2031
    • 12.2.1. Foam Tipped Swabs
    • 12.2.2. Non-woven Swabs
    • 12.2.3. Others
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Influenza
    • 12.3.2. COVID-19
    • 12.3.3. Respiratory Syncytial Virus
    • 12.3.4. Bordetella Pertussis Infection
    • 12.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
    • 12.3.6. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Clinics
    • 12.4.3. Academia & Research Institutes
    • 12.4.4. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Nasopharyngeal Swabs Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2017-2031
    • 13.2.1. Foam Tipped Swabs
    • 13.2.2. Non-woven Swabs
    • 13.2.3. Others
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Influenza
    • 13.3.2. COVID-19
    • 13.3.3. Respiratory Syncytial Virus
    • 13.3.4. Bordetella Pertussis Infection
    • 13.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
    • 13.3.6. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Clinics
    • 13.4.3. Academia & Research Institutes
    • 13.4.4. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Nasopharyngeal Swabs Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2017-2031
    • 14.2.1. Foam Tipped Swabs
    • 14.2.2. Non-woven Swabs
    • 14.2.3. Others
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Influenza
    • 14.3.2. COVID-19
    • 14.3.3. Respiratory Syncytial Virus
    • 14.3.4. Bordetella Pertussis Infection
    • 14.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
    • 14.3.6. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Clinics
    • 14.4.3. Academia & Research Institutes
    • 14.4.4. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2022
  • 15.3. Company Profiles
    • 15.3.1. Thermo Fisher Scientific, Inc.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. C. R. Bard, Inc. (Becton, Dickinson and Company)
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Medical Wire & Equipment (MWE)
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Titan Biotech Ltd.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. COPAN Diagnostics, Inc.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Miraclean Technology Co., Ltd.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Puritan Medical Products
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. YOCON Biology
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Trinity Biotech
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. VIRCELL S.L.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Quidel Corporation
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. SWOT Analysis
      • 15.3.11.5. Strategic Overview

List of Tables

  • Table 1: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 2: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 3: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 4: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 5: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 6: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 7: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 8: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 9: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 10: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 11: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 13: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 14: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 15: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 17: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 18: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 19: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 20: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 21: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 22: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 23: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 24: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031

List of Figures

  • Figure 01: Global Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Nasopharyngeal Swabs Market Value Share, by Type, 2022
  • Figure 03: Global Nasopharyngeal Swabs Market Value Share, by Application, 2022
  • Figure 04: Global Nasopharyngeal Swabs Market Value Share, by End-user, 2022
  • Figure 05: Global Nasopharyngeal Swabs Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 06: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Foam Tipped Swabs, 2017-2031
  • Figure 07: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Non-woven Swabs, 2017-2031
  • Figure 08: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 09: Global Nasopharyngeal Swabs Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 10: Global Nasopharyngeal Swabs Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 11: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Influenza, 2017-2031
  • Figure 12: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by COVID-19, 2017-2031
  • Figure 13: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Respiratory Syncytial Virus, 2017-2031
  • Figure 14: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Bordetella Pertussis Infection, 2017-2031
  • Figure 15: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by MRSA (Methicillin-Resistant Staphylococcus aureus), 2017-2031
  • Figure 16: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 17: Global Nasopharyngeal Swabs Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 18: Global Nasopharyngeal Swabs Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 19: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 20: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Clinics 2017-2032
  • Figure 21: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 22: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Academia & Research Institutes
  • Figure 23: Global Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 24: Global Nasopharyngeal Swabs Market Value Share Analysis, by Region 2022 and 2031
  • Figure 25: Global Nasopharyngeal Swabs Market Attractiveness Analysis, by Region 2023-2031
  • Figure 26: North America Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 27: North America Nasopharyngeal Swabs Market Value Share Analysis, by Country 2022 and 2031
  • Figure 28: North America Nasopharyngeal Swabs Market Attractiveness Analysis, by Country 2023-2031
  • Figure 29: North America Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031
  • Figure 30: North America Nasopharyngeal Swabs Market Attractiveness Analysis, by Type 2023-2031
  • Figure 31: North America Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031
  • Figure 32: North America Nasopharyngeal Swabs Market Attractiveness Analysis, by Application 2023-2031
  • Figure 33: North America Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031
  • Figure 34: North America Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 35: Europe Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 36: Europe Nasopharyngeal Swabs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 37: Europe Nasopharyngeal Swabs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Europe Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031
  • Figure 39: Europe Nasopharyngeal Swabs Market Attractiveness Analysis, by Type 2023-2031
  • Figure 40: Europe Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031
  • Figure 41: Europe Nasopharyngeal Swabs Market Attractiveness Analysis, by Application 2023-2031
  • Figure 42: Europe Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031
  • Figure 43: Europe Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 44: Asia Pacific Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 45: Asia Pacific Nasopharyngeal Swabs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 46: Asia Pacific Nasopharyngeal Swabs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Asia Pacific Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031
  • Figure 48: Asia Pacific Nasopharyngeal Swabs Market Attractiveness Analysis, by Type 2023-2031
  • Figure 49: Asia Pacific Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031
  • Figure 50: Asia Pacific Nasopharyngeal Swabs Market Attractiveness Analysis, by Application 2023-2031
  • Figure 51: Asia Pacific Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031
  • Figure 52: Asia Pacific Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 53: Latin America Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 54: Latin America Nasopharyngeal Swabs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 55: Latin America Nasopharyngeal Swabs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Latin America Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031
  • Figure 57: Latin America Nasopharyngeal Swabs Market Attractiveness Analysis, by Type 2023-2031
  • Figure 58: Latin America Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031
  • Figure 59: Latin America Nasopharyngeal Swabs Market Attractiveness Analysis, by Application 2023-2031
  • Figure 60: Latin America Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031
  • Figure 61: Latin America Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 62: Middle East and Africa Nasopharyngeal Swabs Market Value (US$ Mn), 2017-2031
  • Figure 63: Middle East and Africa Nasopharyngeal Swabs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 64: Middle East and Africa Nasopharyngeal Swabs Market Attractiveness, by Country/Sub-region, 2023-2031
  • Figure 65: Middle East and Africa Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031
  • Figure 66: Middle East and Africa Nasopharyngeal Swabs Market Attractiveness, by Type 2023-2031
  • Figure 67: Middle East and Africa Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031
  • Figure 68: Middle East and Africa Nasopharyngeal Swabs Market Attractiveness, by Application 2023-2031
  • Figure 69: Middle East and Africa Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031
  • Figure 70: Middle East and Africa Nasopharyngeal Swabs Market Attractiveness by End-user 2023-2031
  • Figure 71: Company Share Analysis Nasopharyngeal Swabs, 2022